The chromatin signatures of enhancers and their dynamic regulation

References

• Grosveld F, van Assendelft GB, Greaves DR, et al. high-level expression of the human beta-globin gene in transgenic mice. Cell. 1987;51(6):975–21.
   PubMed Web of Science ®Google Scholar
• Huang J, Liu X, Li D, et al. Dynamic Control of Enhancer Repertoires Drives Lineage and Stage-Specific Transcription during Hematopoiesis. Dev Cell. 2016;36(1):9–23.
   PubMed Web of Science ®Google Scholar
• Lavin Y, Winter D, Blecher-Gonen R, et al. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell. 2014;159(6):1312–1326.
   PubMed Web of Science ®Google Scholar
• Zinzen RP, Girardot C, Gagneur J, et al. Combinatorial binding predicts spatio-temporal cis-regulatory activity. Nature. 2009;462(7269):65–70.
   PubMed Web of Science ®Google Scholar
• Mousavi K, Zare H, Dell’orso S, et al. eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci. Mol Cell. 2013;51(5):606–617.
   PubMed Web of Science ®Google Scholar
• Rahnamoun H, Hong J, Sun Z, et al. Mutant p53 regulates enhancer-associated H3K4 monomethylation through interactions with the methyltransferase MLL4. J Biol Chem. 2018;293(34):13234–13246.
   PubMed Web of Science ®Google Scholar
• Xu J, Shao Z, Glass K, et al. Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis. Dev Cell. 2012;23(4):796–811.
   PubMed Web of Science ®Google Scholar
• Faure AJ, Schmidt D, Watt S, et al. Cohesin regulates tissue-specific expression by stabilizing highly occupied cis -regulatory modules. Genome Res. 2012;22(11):2163–2175.
   PubMed Web of Science ®Google Scholar
• Kubo N, Ishii H, Xiong X, et al. Promoter-proximal CTCF binding promotes distal enhancer-dependent gene activation. Nat Struct Mol Biol. 2021;28(2):152–161.
   PubMed Web of Science ®Google Scholar
• Kagey MH, Newman JJ, Bilodeau S, et al. Mediator and cohesin connect gene expression and chromatin architecture. Nature. 2010;467(1):430–435.
   PubMedGoogle Scholar
• Sooraj D, Sun C, Doan A, et al. MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinase. Mol Cell. 2022;82(1):123–39.e7.
   PubMed Web of Science ®Google Scholar
• Esnault C, Ghavi-Helm Y, Brun S, et al. Mediator-dependent recruitment of TFIIH modules in preinitiation complex. Mol Cell. 2008;31(3):337–346.
   PubMed Web of Science ®Google Scholar
• Soutourina J, Wydau S, Ambroise Y, et al. Direct interaction of RNA polymerase II and mediator required for transcription in vivo. Science. 2011;331(6023):1451–1454.
   PubMed Web of Science ®Google Scholar
• Dorighi KM, Swigut T, Henriques T, et al. Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation. Mol Cell. 2017;66(4):568–76.e4.
   PubMed Web of Science ®Google Scholar
• Gorbovytska V, Kim SK, Kuybu F, et al. Enhancer RNAs stimulate Pol II pause release by harnessing multivalent interactions to NELF. Nat Commun. 2022;13(1):2429.
   PubMed Web of Science ®Google Scholar
• Hsieh CL, Fei T, Chen Y, et al. Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation. Proc Natl Acad Sci U S A. 2014;111(20):7319–7324.
   PubMed Web of Science ®Google Scholar
• Lai F, Orom UA, Cesaroni M, et al. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature. 2013;494(7438):497–501.
   PubMed Web of Science ®Google Scholar
• Li W, Notani D, Ma Q, et al. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature. 2013;498(7455):516–520.
   PubMed Web of Science ®Google Scholar
• Schaukowitch K, Joo JY, Liu X, et al. Enhancer RNA facilitates NELF release from immediate early genes. Mol Cell. 2014;56(1):29–42.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang L, Ren S, et al. Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer. Cell Rep. 2016;15(3):599–610.
   PubMed Web of Science ®Google Scholar
• Song L, Zhang Z, Grasfeder LL, et al. Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Res. 2011;21(10):1757–1767.
   PubMed Web of Science ®Google Scholar
• Thurman RE, Rynes E, Humbert R, et al. The accessible chromatin landscape of the human genome. Nature. 2012;489(7414):75–82.
   PubMed Web of Science ®Google Scholar
• Kim TK, Hemberg M, Gray JM, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature. 2010;465(7295):182–187.
   PubMed Web of Science ®Google Scholar
• Herz HM, Mohan M, Garruss AS, et al. Enhancer-associated H3K4 monomethylation by Trithorax-related, the Drosophila homolog of mammalian Mll3/Mll4. Genes Dev. 2012;26(23):2604–2620.
   PubMed Web of Science ®Google Scholar
• De Santa F, Barozzi I, Mietton F, et al. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol. 2010;8(5):e1000384.
   PubMed Web of Science ®Google Scholar
• Koch F, Fenouil R, Gut M, et al. Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters. Nat Struct Mol Biol. 2011;18(8):956–963.
   PubMed Web of Science ®Google Scholar
• Arner E, Daub CO, Vitting-Seerup K, et al. Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells. Science. 2015;347(6225):1010–1014.
   PubMed Web of Science ®Google Scholar
• Adoue V, Binet B, Malbec A, et al. The Histone Methyltransferase SETDB1 Controls T Helper Cell Lineage Integrity by Repressing Endogenous Retroviruses. Immunity. 2019;50(3):629–44.e8.
   PubMed Web of Science ®Google Scholar
• Barral A, Pozo G, Ducrot L, et al. SETDB1/NSD-dependent H3K9me3/H3K36me3 dual heterochromatin maintains gene expression profiles by bookmarking poised enhancers. Mol Cell. 2022;82(4):816–32.e12.
   PubMed Web of Science ®Google Scholar
• Becker JS, McCarthy RL, Sidoli S, et al. Genomic and Proteomic Resolution of Heterochromatin and Its Restriction of Alternate Fate Genes. Mol Cell. 2017;68(6):1023–37.e15.
   PubMed Web of Science ®Google Scholar
• Creyghton MP, Cheng AW, Welstead GG, et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A. 2010;107(50):21931–21936.
   PubMed Web of Science ®Google Scholar
• Ferrari KJ, Scelfo A, Jammula S, et al. Polycomb-dependent H3K27me1 and H3K27me2 regulate active transcription and enhancer fidelity. Mol Cell. 2014;53(1):49–62.
   PubMed Web of Science ®Google Scholar
• Heintzman ND, Stuart RK, Hon G, et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet. 2007;39(3):311–318.
   PubMed Web of Science ®Google Scholar
• Neumayr C, Haberle V, Serebreni L, et al. Differential cofactor dependencies define distinct types of human enhancers. Nature. 2022;606(7913):406–413.
   PubMed Web of Science ®Google Scholar
• Ostuni R, Piccolo V, Barozzi I, et al. Latent enhancers activated by stimulation in differentiated cells. Cell. 2013;152(1–2):157–171.
   PubMed Web of Science ®Google Scholar
• Rada-Iglesias A, Bajpai R, Swigut T, et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature. 2011;470(7333):279–283.
   PubMed Web of Science ®Google Scholar
• Soufi A, Donahue G, Zaret KS. Facilitators and impediments of the pluripotency reprogramming factors’ initial engagement with the genome. Cell. 2012;151(5):994–1004.
   PubMed Web of Science ®Google Scholar
• Bose DA, Donahue G, Reinberg D, et al. RNA Binding to CBP Stimulates Histone Acetylation and Transcription. Cell. 2017;168(1–2):135–49.e22.
   PubMed Web of Science ®Google Scholar
• Raisner R, Kharbanda S, Jin L, et al. Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. Cell Rep. 2018;24(7):1722–1729.
   PubMed Web of Science ®Google Scholar
• Wang SP, Tang Z, Chen CW, et al. A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription. Mol Cell. 2017;67(2):308–21.e6.
   PubMed Web of Science ®Google Scholar
• Wang A, Yue F, Li Y, et al. Epigenetic priming of enhancers predicts developmental competence of hESC-derived endodermal lineage intermediates. Cell Stem Cell. 2015;16(4):386–399.
   PubMed Web of Science ®Google Scholar
• Beyaz S, Kim JH, Pinello L, et al. The histone demethylase UTX regulates the lineage-specific epigenetic program of invariant natural killer T cells. Nat Immunol. 2017;18(2):184–195.
   PubMed Web of Science ®Google Scholar
• Chen H, Hu B, Horth C, et al. H3K36 dimethylation shapes the epigenetic interaction landscape by directing repressive chromatin modifications in embryonic stem cells. Genome Res. 2022;32(5):825–837.
   PubMed Web of Science ®Google Scholar
• Domcke S, Bardet AF, Adrian Ginno P, et al. Competition between DNA methylation and transcription factors determines binding of NRF1. Nature. 2015;528(7583):575–579.
   PubMed Web of Science ®Google Scholar
• Hon GC, Song CX, Du T, et al. 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation. Mol Cell. 2014;56(2):286–297.
   PubMed Web of Science ®Google Scholar
• Rasmussen KD, Berest I, Keβler S, et al. TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells. Genome Res. 2019;29(4):564–575.
   PubMed Web of Science ®Google Scholar
• Yin Y, Morgunova E, Jolma A, et al. Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science. 2017;356(6337). DOI:10.1126/science.aaj2239.
   Web of Science ®Google Scholar
• Bonn S, Zinzen RP, Girardot C, et al. Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development. Nat Genet. 2012;44(2):148–156.
   PubMed Web of Science ®Google Scholar
• Tomaz RA, Harman JL, Karimlou D, et al. Jmjd2c facilitates the assembly of essential enhancer-protein complexes at the onset of embryonic stem cell differentiation. Development. 2017;144(4):567–579.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Sun L, Chen Z, et al. Predicting enhancer transcription and activity from chromatin modifications. Nucleic Acids Res. 2013;41(22):10032–10043.
   PubMed Web of Science ®Google Scholar
• Spitz F, Furlong EE. Transcription factors: from enhancer binding to developmental control. Nat Rev Genet. 2012;13(9):613–626.
   PubMed Web of Science ®Google Scholar
• Calo E, Wysocka J. Modification of enhancer chromatin: what, how, and why?. Mol Cell. 2013;49(5):825–837.
   PubMed Web of Science ®Google Scholar
• Lewis MW, Li S, Franco HL. Transcriptional control by enhancers and enhancer RNAs. Transcription. 2019;10(4–5):171–186.
   PubMedGoogle Scholar
• Ong CT, Corces VG. Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat Rev Genet. 2011;12(4):283–293.
   PubMed Web of Science ®Google Scholar
• Berman BP, Nibu Y, Pfeiffer BD, et al. Exploiting transcription factor binding site clustering to identify cis-regulatory modules involved in pattern formation in the Drosophila genome. Proc Natl Acad Sci U S A. 2002;99(2):757–762.
   PubMed Web of Science ®Google Scholar
• Blum R, Vethantham V, Bowman C, et al. Genome-wide identification of enhancers in skeletal muscle: the role of MyoD1. Genes Dev. 2012;26(24):2763–2779.
   PubMed Web of Science ®Google Scholar
• Shen Y, Yue F, McCleary DF, et al. A map of the cis-regulatory sequences in the mouse genome. Nature. 2012;488(7409):116–120.
   PubMed Web of Science ®Google Scholar
• Liu Z, Merkurjev D, Yang F, et al. Enhancer activation requires trans-recruitment of a mega transcription factor complex. Cell. 2014;159(2):358–373.
   PubMed Web of Science ®Google Scholar
• Melo CA, Drost J, Wijchers PJ, et al. eRNAs are required for p53-dependent enhancer activity and gene transcription. Mol Cell. 2013;49(3):524–535.
   PubMed Web of Science ®Google Scholar
• Najafova Z, Tirado-Magallanes R, Subramaniam M, et al. BRD4 localization to lineage-specific enhancers is associated with a distinct transcription factor repertoire. Nucleic Acids Res. 2017;45(1):127–141.
   PubMed Web of Science ®Google Scholar
• Davis JE, Insigne KD, Jones EM, et al. Dissection of c-AMP response element architecture by using genomic and episomal massively parallel reporter assays. Cell Syst. 2020;11(1):75–85.e7.
   PubMed Web of Science ®Google Scholar
• de Almeida BP, Reiter F, Pagani M, et al. DeepSTARR predicts enhancer activity from DNA sequence and enables the de novo design of synthetic enhancers. Nat Genet. 2022;54(5):613–624.
   PubMed Web of Science ®Google Scholar
• King DM, Hong CKY, Shepherdson JL, et al. Synthetic and genomic regulatory elements reveal aspects of cis-regulatory grammar in mouse embryonic stem cells. Elife. 2020;9. DOI:10.7554/eLife.41279
   Web of Science ®Google Scholar
• Nair SJ, Yang L, Meluzzi D, et al. Phase separation of ligand-activated enhancers licenses cooperative chromosomal enhancer assembly. Nat Struct Mol Biol. 2019;26(3):193–203.
   PubMed Web of Science ®Google Scholar
• Shrinivas K, Sabari BR, Coffey EL, et al. Enhancer features that drive formation of transcriptional condensates. Mol Cell. 2019;75(3):549–61.e7.
   PubMed Web of Science ®Google Scholar
• Lam MT, Cho H, Lesch HP, et al. Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature. 2013;498(7455):511–515.
   PubMed Web of Science ®Google Scholar
• Respuela P, Nikolić M, Tan M, et al. Foxd3 promotes exit from naive pluripotency through enhancer decommissioning and inhibits germline specification. Cell Stem Cell. 2016;18(1):118–133.
   PubMed Web of Science ®Google Scholar
• Lee JE, Park YK, Park S, et al. Brd4 binds to active enhancers to control cell identity gene induction in adipogenesis and myogenesis. Nat Commun. 2017;8(1):2217.
   PubMedGoogle Scholar
• Jia P, Li X, Wang X, et al. ZMYND8 mediated liquid condensates spatiotemporally decommission the latent super-enhancers during macrophage polarization. Nat Commun. 2021;12(1):6535.
   PubMed Web of Science ®Google Scholar
• Banerji J, Rusconi S, Schaffner W. Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. Cell. 1981;27(2):299–308.
   PubMed Web of Science ®Google Scholar
• Inoue F, Ahituv N. Decoding enhancers using massively parallel reporter assays. Genomics. 2015;106(3):159–164.
   PubMed Web of Science ®Google Scholar
• White MA, Myers CA, Corbo JC, et al. Massively parallel in vivo enhancer assay reveals that highly local features determine the cis -regulatory function of ChIP-seq peaks. Proc Natl Acad Sci U S A. 2013;110(29):11952–11957.
   PubMed Web of Science ®Google Scholar
• Patwardhan RP, Hiatt JB, Witten DM, et al. Massively parallel functional dissection of mammalian enhancers in vivo. Nat Biotechnol. 2012;30(3):265–270.
   PubMed Web of Science ®Google Scholar
• Martinez-Ara M, Comoglio F, van Arensbergen J, et al. Systematic analysis of intrinsic enhancer-promoter compatibility in the mouse genome. Mol Cell. 2022;82(13):2519–2531.e6.
   PubMedGoogle Scholar
• Kvon EZ. Using transgenic reporter assays to functionally characterize enhancers in animals. Genomics. 2015;106(3):185–192.
   PubMed Web of Science ®Google Scholar
• Jenett A, Rubin GM, Ngo TT, et al. A GAL4-driver line resource for Drosophila neurobiology. Cell Rep. 2012;2(4):991–1001.
   PubMed Web of Science ®Google Scholar
• Lettice LA, Heaney SJ, Purdie LA, et al. A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum Mol Genet. 2003;12(14):1725–1735.
   PubMed Web of Science ®Google Scholar
• Rossant J, Zirngibl R, Cado D, et al. Expression of a retinoic acid response element-hsplacZ transgene defines specific domains of transcriptional activity during mouse embryogenesis. Genes Dev. 1991;5(8):1333–1344.
   PubMed Web of Science ®Google Scholar
• Marinić M, Aktas T, Ruf S, et al. An integrated holo-enhancer unit defines tissue and gene specificity of the Fgf8 regulatory landscape. Dev Cell. 2013;24(5):530–542.
   PubMed Web of Science ®Google Scholar
• Spitz F, Gonzalez F, Duboule D. A global control region defines a chromosomal regulatory landscape containing the HoxD cluster. Cell. 2003;113(3):405–417.
   PubMed Web of Science ®Google Scholar
• Weber F, de Villiers J, Schaffner W. An SV40 “enhancer trap” incorporates exogenous enhancers or generates enhancers from its own sequences. Cell. 1984;36(4):983–992.
   PubMed Web of Science ®Google Scholar
• Kothary R, Clapoff S, Darling S, et al. Inducible expression of an hsp68-lacZ hybrid gene in transgenic mice. Development. 1989;105(4):707–714.
   PubMed Web of Science ®Google Scholar
• Bellen HJ, O’Kane CJ, Wilson C, et al. P-element-mediated enhancer detection: a versatile method to study development in Drosophila. Genes Dev. 1989;3(9):1288–1300.
   PubMed Web of Science ®Google Scholar
• Doyle HJ, Kraut R, Levine M. Spatial regulation of zerknüllt: a dorsal-ventral patterning gene in Drosophila. Genes Dev. 1989;3(10):1518–1533.
   PubMed Web of Science ®Google Scholar
• Gisselbrecht SS, Barrera LA, Porsch M, et al. Highly parallel assays of tissue-specific enhancers in whole Drosophila embryos. Nat Methods. 2013;10(8):774–780.
   PubMed Web of Science ®Google Scholar
• Diao Y, Fang R, Li B, et al. A tiling-deletion-based genetic screen for cis-regulatory element identification in mammalian cells. Nat Methods. 2017;14(6):629–635.
   PubMed Web of Science ®Google Scholar
• Rajagopal N, Srinivasan S, Kooshesh K, et al. High-throughput mapping of regulatory DNA. Nat Biotechnol. 2016;34(2):167–174.
   PubMed Web of Science ®Google Scholar
• Weintraub AS, Li CH, Zamudio AV, et al. YY1 Is a Structural Regulator of Enhancer-Promoter Loops. Cell. 2017;171(7):1573–88.e28.
   PubMed Web of Science ®Google Scholar
• Fournier M, Bourriquen G, Lamaze FC, et al. FOXA and master transcription factors recruit Mediator and Cohesin to the core transcriptional regulatory circuitry of cancer cells. Sci Rep. 2016;6(1):34962.
   PubMedGoogle Scholar
• Thiecke MJ, Wutz G, Muhar M, et al. Cohesin-dependent and -independent mechanisms mediate chromosomal contacts between promoters and enhancers. Cell Rep. 2020;32(3):107929.
   PubMed Web of Science ®Google Scholar
• Crump NT, Ballabio E, Godfrey L, et al. BET inhibition disrupts transcription but retains enhancer-promoter contact. Nat Commun. 2021;12(1):223.
   PubMed Web of Science ®Google Scholar
• Boija A, Klein IA, Sabari BR, et al. Transcription factors activate genes through the phase-separation capacity of their activation domains. Cell. 2018;175(7):1842–55.e16.
   PubMed Web of Science ®Google Scholar
• Cho WK, Spille JH, Hecht M, et al. Mediator and RNA polymerase II clusters associate in transcription-dependent condensates. Science. 2018;361(6400):412–415.
   PubMed Web of Science ®Google Scholar
• Sabari BR, Dall’Agnese A, Boija A, et al. Coactivator condensation at super-enhancers links phase separation and gene control. Science. 2018;361(6400). DOI:10.1126/science.aar3958.
   PubMed Web of Science ®Google Scholar
• Schoenfelder S, Furlan-Magaril M, Mifsud B, et al. The pluripotent regulatory circuitry connecting promoters to their long-range interacting elements. Genome Res. 2015;25(4):582–597.
   PubMed Web of Science ®Google Scholar
• Sun F, Chronis C, Kronenberg M, et al. Promoter-enhancer communication occurs primarily within insulated neighborhoods. Mol Cell. 2019;73(2):250–63.e5.
   PubMed Web of Science ®Google Scholar
• Zuin J, Roth G, Zhan Y, et al. Nonlinear control of transcription through enhancer-promoter interactions. Nature. 2022;604(7906):571–577.
   PubMed Web of Science ®Google Scholar
• Cao F, Fang Y, Tan HK, et al. Super-enhancers and broad H3K4me3 domains form complex gene regulatory circuits involving chromatin interactions. Sci Rep. 2017;7(1):2186.
   PubMedGoogle Scholar
• Andersson R, Gebhard C, Miguel-Escalada I, et al. An atlas of active enhancers across human cell types and tissues. Nature. 2014;507(7493):455–461.
   PubMed Web of Science ®Google Scholar
• Choi J, Lysakovskaia K, Stik G, et al. Evidence for additive and synergistic action of mammalian enhancers during cell fate determination. Elife. 2021;10. DOI:10.7554/eLife.65381.
   Web of Science ®Google Scholar
• Cruz-Molina S, Respuela P, Tebartz C, et al. PRC2 facilitates the regulatory topology required for poised enhancer function during pluripotent stem cell differentiation. Cell Stem Cell. 2017;20(5):689–705.e9.
   PubMed Web of Science ®Google Scholar
• Benabdallah NS, Williamson I, Illingworth RS, et al. Decreased Enhancer-Promoter Proximity Accompanying Enhancer Activation. Mol Cell. 2019;76(3):473–84.e7.
   PubMed Web of Science ®Google Scholar
• Hong JW, Hendrix DA, Levine MS. Shadow enhancers as a source of evolutionary novelty. Science. 2008;321(5894):1314.
   PubMed Web of Science ®Google Scholar
• Moorthy SD, Davidson S, Shchuka VM, et al. Enhancers and super-enhancers have an equivalent regulatory role in embryonic stem cells through regulation of single or multiple genes. Genome Res. 2017;27(2):246–258.
   PubMed Web of Science ®Google Scholar
• Lovén J, Hoke HA, Lin CY, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153(2):320–334.
   PubMed Web of Science ®Google Scholar
• El Khattabi L, Zhao H, Kalchschmidt J, et al. A pliable mediator acts as a functional rather than an architectural bridge between promoters and enhancers. Cell. 2019;178(5):1145–58.e20.
   PubMed Web of Science ®Google Scholar
• Core L, Adelman K. Promoter-proximal pausing of RNA polymerase II: a nexus of gene regulation. Genes Dev. 2019;33(15–16):960–982.
   PubMed Web of Science ®Google Scholar
• Baek HJ, Kang YK, Roeder RG. Human Mediator enhances basal transcription by facilitating recruitment of transcription factor IIB during preinitiation complex assembly. J Biol Chem. 2006;281(22):15172–15181.
   PubMed Web of Science ®Google Scholar
• Donner AJ, Ebmeier CC, Taatjes DJ, et al. CDK8 is a positive regulator of transcriptional elongation within the serum response network. Nat Struct Mol Biol. 2010;17(2):194–201.
   PubMed Web of Science ®Google Scholar
• Galbraith MD, Allen MA, Bensard CL, et al. HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. Cell. 2013;153(6):1327–1339.
   PubMed Web of Science ®Google Scholar
• Hou TY, Kraus WL. Analysis of estrogen-regulated enhancer RNAs identifies a functional motif required for enhancer assembly and gene expression. Cell Rep. 2022;39(11):110944.
   PubMed Web of Science ®Google Scholar
• Liu W, Ma Q, Wong K, et al. Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release. Cell. 2013;155(7):1581–1595.
   PubMed Web of Science ®Google Scholar
• Ernst J, Kheradpour P, Mikkelsen TS, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature. 2011;473(7345):43–49.
   PubMed Web of Science ®Google Scholar
• Hah N, Murakami S, Nagari A, et al. Enhancer transcripts mark active estrogen receptor binding sites. Genome Res. 2013;23(8):1210–1223.
   PubMed Web of Science ®Google Scholar
• Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells. Nature. 2012;489(7414):101–108.
   PubMed Web of Science ®Google Scholar
• Henriques T, Scruggs BS, Inouye MO, et al. Widespread transcriptional pausing and elongation control at enhancers. Genes Dev. 2018;32(1):26–41.
   PubMed Web of Science ®Google Scholar
• Yang XH, Nadadur RD, Hilvering CR, et al. Transcription-factor-dependent enhancer transcription defines a gene regulatory network for cardiac rhythm. Elife. 2017;6:e31683.
   PubMed Web of Science ®Google Scholar
• Visel A, Taher L, Girgis H, et al. A high-resolution enhancer atlas of the developing telencephalon. Cell. 2013;152(4):895–908.
   PubMed Web of Science ®Google Scholar
• Heintzman ND, Hon GC, Hawkins RD, et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature. 2009;459(7243):108–112.
   PubMed Web of Science ®Google Scholar
• Ghisletti S, Barozzi I, Mietton F, et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity. 2010;32(3):317–328.
   PubMed Web of Science ®Google Scholar
• Cirillo LA, Lin FR, Cuesta I, et al. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol Cell. 2002;9(2):279–289.
   PubMed Web of Science ®Google Scholar
• Zaret KS. Pioneer Transcription Factors Initiating Gene Network Changes. Annu Rev Genet. 2020;54(1):367–385.
   PubMedGoogle Scholar
• King HW, Klose RJ. The pioneer factor OCT4 requires the chromatin remodeller BRG1 to support gene regulatory element function in mouse embryonic stem cells. Elife. 2017;6:e22631.
   PubMed Web of Science ®Google Scholar
• Minderjahn J, Schmidt A, Fuchs A, et al. Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1. Nat Commun. 2020;11(1):402.
   PubMed Web of Science ®Google Scholar
• Takaku M, Grimm SA, Shimbo T, et al. GATA3-dependent cellular reprogramming requires activation-domain dependent recruitment of a chromatin remodeler. Genome Biol. 2016;17(1):36.
   PubMedGoogle Scholar
• Park YK, Lee JE, Yan Z, et al. Interplay of BAF and MLL4 promotes cell type-specific enhancer activation. Nat Commun. 2021;12(1):1630.
   PubMed Web of Science ®Google Scholar
• Alexander JM, Hota SK, He D, et al. Brg1 modulates enhancer activation in mesoderm lineage commitment. Development. 2015;142(8):1418–1430.
   PubMed Web of Science ®Google Scholar
• Yan J, Chen SA, Local A, et al. Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers. Cell Res. 2018;28(3):387.
   PubMed Web of Science ®Google Scholar
• Kang Y, Kim YW, Kang J, et al. Histone H3K4me1 and H3K27ac play roles in nucleosome eviction and eRNA transcription, respectively, at enhancers. Faseb j. 2021;35(8):e21781.
   PubMed Web of Science ®Google Scholar
• Wang C, Lee JE, Lai B, et al. Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition. Proc Natl Acad Sci U S A. 2016;113(42):11871–11876.
   PubMed Web of Science ®Google Scholar
• Local A, Huang H, Albuquerque CP, et al. Identification of H3K4me1-associated proteins at mammalian enhancers. Nat Genet. 2018;50(1):73–82.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhao Z, Ozark PA, et al. Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. Nat Med. 2018;24(6):758–769.
   PubMed Web of Science ®Google Scholar
• Martire S, Nguyen J, Sundaresan A, et al. Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. BMC Mol Cell Biol. 2020;21(1):55.
   PubMed Web of Science ®Google Scholar
• Narita T, Ito S, Higashijima Y, et al. Enhancers are activated by p300/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release. Mol Cell. 2021;81(10):2166–82.e6.
   PubMed Web of Science ®Google Scholar
• Hnisz D, Abraham BJ, Lee TI, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155(4):934–947.
   PubMed Web of Science ®Google Scholar
• Hnisz D, Schuijers J, Lin CY, et al. Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Mol Cell. 2015;58(2):362–370.
   PubMed Web of Science ®Google Scholar
• Lee BK, Jang YJ, Kim M, et al. Super-enhancer-guided mapping of regulatory networks controlling mouse trophoblast stem cells. Nat Commun. 2019;10(1):4749.
   PubMedGoogle Scholar
• Witte S, Bradley A, Enright AJ, et al. High-density P300 enhancers control cell state transitions. BMC Genomics. 2015;16(1):903.
   PubMedGoogle Scholar
• Khan A, Mathelier A, Zhang X. Super-enhancers are transcriptionally more active and cell type-specific than stretch enhancers. Epigenetics. 2018;13(9):910–922.
   PubMed Web of Science ®Google Scholar
• Sankar A, Mohammad F, Sundaramurthy AK, et al. Histone editing elucidates the functional roles of H3K27 methylation and acetylation in mammals. Nat Genet. 2022;54(6):754–760.
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang Z, Dong Q, et al. Histone H3K27 acetylation is dispensable for enhancer activity in mouse embryonic stem cells. Genome Biol. 2020;21(1):45.
   PubMed Web of Science ®Google Scholar
• Galle E, Wong CW, Ghosh A, et al. H3K18 lactylation marks tissue-specific active enhancers. Genome Biol. 2022;23(1):207.
   PubMed Web of Science ®Google Scholar
• Soldi M, Mari T, Nicosia L, et al. Chromatin proteomics reveals novel combinatorial histone modification signatures that mark distinct subpopulations of macrophage enhancers. Nucleic Acids Res. 2017;45(21):12195–12213.
   PubMed Web of Science ®Google Scholar
• Wang X, Rosikiewicz W, Sedkov Y, et al. The MLL3/4 complexes and MiDAC co-regulate H4K20ac to control a specific gene expression program. Life Sci Alliance. 2022;5(11):e202201572.
   PubMed Web of Science ®Google Scholar
• Godfrey L, Crump NT, Thorne R, et al. DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation. Nat Commun. 2019;10(1):2803.
   PubMedGoogle Scholar
• Weinberg DN, Papillon-Cavanagh S, Chen H, et al. The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape. Nature. 2019;573(7773):281–286.
   PubMed Web of Science ®Google Scholar
• Xu W, Li J, Rong B, et al. DNMT3A reads and connects histone H3K36me2 to DNA methylation. Protein Cell. 2020;11(2):150–154.
   PubMed Web of Science ®Google Scholar
• Shen C, Ipsaro JJ, Shi J, et al. NSD3-short is an adaptor protein that couples BRD4 to the CHD8 chromatin remodeler. Mol Cell. 2015;60(6):847–859.
   PubMed Web of Science ®Google Scholar
• Kanno T, Kanno Y, LeRoy G, et al. BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones. Nat Struct Mol Biol. 2014;21(12):1047–1057.
   PubMed Web of Science ®Google Scholar
• Jang MK, Mochizuki K, Zhou M, et al. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell. 2005;19(4):523–534.
   PubMed Web of Science ®Google Scholar
• Yang Z, Yik JH, Chen R, et al. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell. 2005;19(4):535–545.
   PubMed Web of Science ®Google Scholar
• Devaiah BN, Lewis BA, Cherman N, et al. BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain. Proc Natl Acad Sci U S A. 2012;109(18):6927–6932.
   PubMed Web of Science ®Google Scholar
• Cinghu S, Yang P, Kosak JP, et al. Intragenic Enhancers Attenuate Host Gene Expression. Mol Cell. 2017;68(1):104–17.e6.
   PubMed Web of Science ®Google Scholar
• Zentner GE, Tesar PJ, Scacheri PC. Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions. Genome Res. 2011;21(8):1273–1283.
   PubMed Web of Science ®Google Scholar
• Wang AH, Juan AH, Ko KD, et al. The Elongation Factor Spt6 Maintains ESC Pluripotency by Controlling Super-Enhancers and Counteracting Polycomb Proteins. Mol Cell. 2017;68(2):398–413.e6.
   PubMed Web of Science ®Google Scholar
• Pefanis E, Wang J, Rothschild G, et al. RNA exosome-regulated long non-coding RNA transcription controls super-enhancer activity. Cell. 2015;161(4):774–789.
   PubMed Web of Science ®Google Scholar
• Yang M, Lee JH, Zhang Z, et al. Enhancer RNAs mediate estrogen-induced decommissioning of selective enhancers by recruiting ERα and its cofactor. Cell Rep. 2020;31(12):107803.
   PubMed Web of Science ®Google Scholar
• Kowalczyk MS, Hughes JR, Garrick D, et al. Intragenic enhancers act as alternative promoters. Mol Cell. 2012;45(4):447–458.
   PubMed Web of Science ®Google Scholar
• Tang WWC, Castillo-Venzor A, Gruhn WH, et al. Sequential enhancer state remodelling defines human germline competence and specification. Nat Cell Biol. 2022;24(4):448–460.
   PubMed Web of Science ®Google Scholar
• Nord AS, Blow MJ, Attanasio C, et al. Rapid and pervasive changes in genome-wide enhancer usage during mammalian development. Cell. 2013;155(7):1521–1531.
   PubMed Web of Science ®Google Scholar
• Tao L, Yu HV, Llamas J, et al. Enhancer decommissioning imposes an epigenetic barrier to sensory hair cell regeneration. Dev Cell. 2021;56(17):2471–85.e5.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Loh YE, Rajarajan P, et al. The methyltransferase SETDB1 regulates a large neuron-specific topological chromatin domain. Nat Genet. 2017;49(8):1239–1250.
   PubMed Web of Science ®Google Scholar
• Smith CL, Poleshko A, Epstein JA. The nuclear periphery is a scaffold for tissue-specific enhancers. Nucleic Acids Res. 2021;49(11):6181–6195.
   PubMed Web of Science ®Google Scholar
• Zhu Y, van Essen D, Saccani S. Cell-type-specific control of enhancer activity by H3K9 trimethylation. Mol Cell. 2012;46(4):408–423.
   PubMed Web of Science ®Google Scholar
• Zylicz JJ, Dietmann S, Günesdogan U, et al. Chromatin dynamics and the role of G9a in gene regulation and enhancer silencing during early mouse development. Elife. 2015;4:e09517.
   Web of Science ®Google Scholar
• Salzberg AC, Harris-Becker A, Popova EY, et al. Genome-wide mapping of histone H3K9me2 in acute myeloid leukemia reveals large chromosomal domains associated with massive gene silencing and sites of genome instability. PLoS One. 2017;12(3):e0173723.
   PubMed Web of Science ®Google Scholar
• Wen B, Wu H, Shinkai Y, et al. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat Genet. 2009;41(2):246–250.
   PubMed Web of Science ®Google Scholar
• Li K, Liu Y, Cao H, et al. Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing. Nat Commun. 2020;11(1):485.
   PubMed Web of Science ®Google Scholar
• Iwafuchi-Doi M, Donahue G, Kakumanu A, et al. The Pioneer Transcription Factor FoxA Maintains an Accessible Nucleosome Configuration at Enhancers for Tissue-Specific Gene Activation. Mol Cell. 2016;62(1):79–91.
   PubMed Web of Science ®Google Scholar
• Wang D, Garcia-Bassets I, Benner C, et al. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature. 2011;474(7351):390–394.
   PubMed Web of Science ®Google Scholar
• Meers MP, Janssens DH, Henikoff S. Pioneer factor-nucleosome binding events during differentiation are motif encoded. Mol Cell. 2019;75(3):562–75.e5.
   PubMed Web of Science ®Google Scholar
• Brunelle M, Nordell Markovits A, Rodrigue S, et al. The histone variant H2A.Z is an important regulator of enhancer activity. Nucleic Acids Res. 2015;43(20):9742–9756.
   PubMed Web of Science ®Google Scholar
• Deaton AM, Gómez-Rodríguez M, Mieczkowski J, et al. Enhancer regions show high histone H3.3 turnover that changes during differentiation. Elife. 2016;5. DOI:10.7554/eLife.15316.
   PubMed Web of Science ®Google Scholar
• He HH, Meyer CA, Shin H, et al. Nucleosome dynamics define transcriptional enhancers. Nat Genet. 2010;42(4):343–347.
   PubMed Web of Science ®Google Scholar
• Kraushaar DC, Jin W, Maunakea A, et al. Genome-wide incorporation dynamics reveal distinct categories of turnover for the histone variant H3.3. Genome Biol. 2013;14(10):R121.
   PubMed Web of Science ®Google Scholar
• Lee K, Cho H, Rickert RW, et al. FOXA2 Is required for enhancer priming during pancreatic differentiation. Cell Rep. 2019;28(2):382–93.e7.
   PubMed Web of Science ®Google Scholar
• Lupien M, Eeckhoute J, Meyer CA, et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell. 2008;132(6):958–970.
   PubMed Web of Science ®Google Scholar
• Mayran A, Khetchoumian K, Hariri F, et al. Pioneer factor Pax7 deploys a stable enhancer repertoire for specification of cell fate. Nat Genet. 2018;50(2):259–269.
   PubMed Web of Science ®Google Scholar
• Jozwik KM, Chernukhin I, Serandour AA, et al. FOXA1 Directs H3K4 monomethylation at enhancers via recruitment of the methyltransferase MLL3. Cell Rep. 2016;17(10):2715–2723.
   PubMed Web of Science ®Google Scholar
• Martire S, Gogate AA, Whitmill A, et al. Phosphorylation of histone H3.3 at serine 31 promotes p300 activity and enhancer acetylation. Nat Genet. 2019;51(6):941–946.
   PubMed Web of Science ®Google Scholar
• Feldmann A, Ivanek R, Murr R, et al. Transcription factor occupancy can mediate active turnover of DNA methylation at regulatory regions. PLoS Genet. 2013;9(12):e1003994.
   PubMed Web of Science ®Google Scholar
• Stadler MB, Murr R, Burger L, et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature. 2011;480(7378):490–495.
   PubMed Web of Science ®Google Scholar
• Charlton J, Jung EJ, Mattei AL, et al. TETs compete with DNMT3 activity in pluripotent cells at thousands of methylated somatic enhancers. Nat Genet. 2020;52(8):819–827.
   PubMed Web of Science ®Google Scholar
• Ziller MJ, Gu H, Müller F, et al. Charting a dynamic DNA methylation landscape of the human genome. Nature. 2013;500(7463):477–481.
   PubMed Web of Science ®Google Scholar
• Wiench M, John S, Baek S, et al. DNA methylation status predicts cell type-specific enhancer activity. Embo j. 2011;30(15):3028–3039.
   PubMed Web of Science ®Google Scholar
• Bell AC, Felsenfeld G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature. 2000;405(6785):482–485.
   PubMed Web of Science ®Google Scholar
• Hark AT, Schoenherr CJ, Katz DJ, et al. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature. 2000;405(6785):486–489.
   PubMed Web of Science ®Google Scholar
• Song Y, van den Berg PR, Markoulaki S, et al. Dynamic enhancer DNA methylation as basis for transcriptional and cellular heterogeneity of ESCs. Mol Cell. 2019;75(5):905–20.e6.
   PubMed Web of Science ®Google Scholar
• Lu F, Liu Y, Jiang L, et al. Role of Tet proteins in enhancer activity and telomere elongation. Genes Dev. 2014;28(19):2103–2119.
   PubMed Web of Science ®Google Scholar
• Wang L, Ozark PA, Smith ER, et al. TET2 coactivates gene expression through demethylation of enhancers. Sci Adv. 2018;4(11):eaau6986.
   PubMed Web of Science ®Google Scholar
• Rinaldi L, Datta D, Serrat J, et al. Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis. Cell Stem Cell. 2016;19(4):491–501.
   PubMed Web of Science ®Google Scholar
• Hu S, Wan J, Su Y, et al. DNA methylation presents distinct binding sites for human transcription factors. Elife. 2013;2:e00726.
   PubMed Web of Science ®Google Scholar
• Yu M, Hon GC, Szulwach KE, et al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell. 2012;149(6):1368–1380.
   PubMed Web of Science ®Google Scholar
• Battaglia S, Dong K, Wu J, et al. Long-range phasing of dynamic, tissue-specific and allele-specific regulatory elements. Nat Genet. 2022;54(10):1504–1513.
   PubMed Web of Science ®Google Scholar
• Gozdecka M, Meduri E, Mazan M, et al. UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs. Nat Genet. 2018;50(6):883–894.
   PubMed Web of Science ®Google Scholar
• Yuan W, Xu M, Huang C, et al. H3K36 methylation antagonizes PRC2-mediated H3K27 methylation. J Biol Chem. 2011;286(10):7983–7989.
   PubMed Web of Science ®Google Scholar
• Streubel G, Watson A, Jammula SG, et al. The H3K36me2 methyltransferase Nsd1 demarcates PRC2-mediated H3K27me2 and H3K27me3 domains in embryonic stem cells. Mol Cell. 2018;70:371–9.e5.
   PubMed Web of Science ®Google Scholar
• Yuan S, Natesan R, Sanchez-Rivera FJ, et al. Global regulation of the histone mark H3K36me2 underlies epithelial plasticity and metastatic progression. Cancer Discov. 2020;10(6):854–871.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yan X, Feng X, et al. Setd2 regulates quiescence and differentiation of adult hematopoietic stem cells by restricting RNA polymerase II elongation. Haematologica. 2018;103(7):1110–1123.
   PubMed Web of Science ®Google Scholar
• Farhangdoost N, Horth C, Hu B, et al. Chromatin dysregulation associated with NSD1 mutation in head and neck squamous cell carcinoma. Cell Rep. 2021;34(8):108769.
   PubMed Web of Science ®Google Scholar
• Lhoumaud P, Badri S, Rodriguez-Hernaez J, et al. NSD2 overexpression drives clustered chromatin and transcriptional changes in a subset of insulated domains. Nat Commun. 2019;10(1):4843.
   PubMedGoogle Scholar
• Popovic R, Martinez-Garcia E, Giannopoulou EG, et al. Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation. PLoS Genet. 2014;10(9):e1004566.
   PubMed Web of Science ®Google Scholar
• Kerenyi MA, Shao Z, Hsu YJ, et al. Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation. Elife. 2013;2:e00633.
   PubMed Web of Science ®Google Scholar
• Vinckier NK, Patel NA, Geusz RJ, et al. LSD1-mediated enhancer silencing attenuates retinoic acid signalling during pancreatic endocrine cell development. Nat Commun. 2020;11(1):2082.
   PubMed Web of Science ®Google Scholar
• Whyte WA, Bilodeau S, Orlando DA, et al. Enhancer decommissioning by LSD1 during embryonic stem cell differentiation. Nature. 2012;482(7384):221–225.
   PubMed Web of Science ®Google Scholar
• Outchkourov NS, Muiño JM, Kaufmann K, et al. Balancing of histone H3K4 methylation states by the Kdm5c/SMCX histone demethylase modulates promoter and enhancer function. Cell Rep. 2013;3(4):1071–1079.
   PubMed Web of Science ®Google Scholar
• Scandaglia M, Lopez-Atalaya JP, Medrano-Fernandez A, et al. Loss of Kdm5c causes spurious transcription and prevents the fine-tuning of activity-regulated enhancers in neurons. Cell Rep. 2017;21(1):47–59.
   PubMed Web of Science ®Google Scholar
• Shen H, Xu W, Guo R, et al. Suppression of enhancer overactivation by a RACK7-histone demethylase complex. Cell. 2016;165(2):331–342.
   PubMed Web of Science ®Google Scholar
• Johnson JL, Georgakilas G, Petrovic J, et al. Lineage-determining transcription factor TCF-1 initiates the epigenetic identity of T Cells. Immunity. 2018;48(2):243–57.e10.
   PubMed Web of Science ®Google Scholar
• Ninova M, Fejes Tóth K, Aravin AA. The control of gene expression and cell identity by H3K9 trimethylation. Development. 2019;146(19). DOI:10.1242/dev.181180
   PubMed Web of Science ®Google Scholar
• Matoba S, Liu Y, Lu F, et al. Embryonic development following somatic cell nuclear transfer impeded by persisting histone methylation. Cell. 2014;159(4):884–895.
   PubMed Web of Science ®Google Scholar
• Hawkins RD, Hon GC, Lee LK, et al. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell. 2010;6(5):479–491.
   PubMed Web of Science ®Google Scholar
• Nicetto D, Donahue G, Jain T, et al. H3K9me3-heterochromatin loss at protein-coding genes enables developmental lineage specification. Science. 2019;363(6424):294–297.
   PubMed Web of Science ®Google Scholar
• Rebollo R, Karimi MM, Bilenky M, et al. Retrotransposon-induced heterochromatin spreading in the mouse revealed by insertional polymorphisms. PLoS Genet. 2011;7(9):e1002301.
   PubMed Web of Science ®Google Scholar
• Karimi MM, Goyal P, Maksakova IA, et al. DNA methylation and SETDB1/H3K9me3 regulate predominantly distinct sets of genes, retroelements, and chimeric transcripts in mESCs. Cell Stem Cell. 2011;8(6):676–687.
   PubMed Web of Science ®Google Scholar
• Montavon T, Shukeir N, Erikson G, et al. Complete loss of H3K9 methylation dissolves mouse heterochromatin organization. Nat Commun. 2021;12(1):4359.
   PubMed Web of Science ®Google Scholar
• Mauser R, Kungulovski G, Keup C, et al. Application of dual reading domains as novel reagents in chromatin biology reveals a new H3K9me3 and H3K36me2/3 bivalent chromatin state. Epigenetics Chromatin. 2017;10(1):45.
   PubMedGoogle Scholar
• Yuan W, Xie J, Long C, et al. Heterogeneous nuclear ribonucleoprotein L Is a subunit of human KMT3a/Set2 complex required for H3 Lys-36 trimethylation activity in vivo. J Biol Chem. 2009;284(23):15701–15707.
   PubMed Web of Science ®Google Scholar
• Tiedemann RL, Hlady RA, Hanavan PD, et al. Dynamic reprogramming of DNA methylation in SETD2-deregulated renal cell carcinoma. Oncotarget. 2016;7(2):1927–1946.
   PubMedGoogle Scholar
• Scionti I, Hayashi S, Mouradian S, et al. LSD1 Controls Timely MyoD Expression via MyoD Core Enhancer Transcription. Cell Rep. 2017;18(8):1996–2006.
   PubMed Web of Science ®Google Scholar
• Voon HPJ, Udugama M, Lin W, et al. Inhibition of a K9/K36 demethylase by an H3.3 point mutation found in paediatric glioblastoma. Nat Commun. 2018;9(1):3142.
   PubMedGoogle Scholar
• Chuong EB, Rumi MA, Soares MJ, et al. Endogenous retroviruses function as species-specific enhancer elements in the placenta. Nat Genet. 2013;45(3):325–329.
   PubMed Web of Science ®Google Scholar
• Sundaram V, Choudhary MN, Pehrsson E, et al. Functional cis-regulatory modules encoded by mouse-specific endogenous retrovirus. Nat Commun. 2017;8(1):14550.
   PubMedGoogle Scholar
• Todd CD, Ö D, Taylor D, et al. Functional evaluation of transposable elements as enhancers in mouse embryonic and trophoblast stem cells. Elife. 2019;8:e44344.
   PubMed Web of Science ®Google Scholar
• Xu R, Li S, Wu Q, et al. Stage-specific H3K9me3 occupancy ensures retrotransposon silencing in human pre-implantation embryos. Cell Stem Cell. 2022;29(7):1051–66.e8.
   PubMed Web of Science ®Google Scholar